Cengild Medical Bhd (XKLS:0243) Ending Cash Position: RM36.36 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XKLS:0243 Cengild Medical Bhd XKLS:0243
61 GF Score
Price RM0.19
GF Value RM0.29
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is Cengild Medical Bhd Ending Cash Position?

Cengild Medical Bhd XKLS:0243 -2.56% 61 Ending Cash Position is RM36.36 Mil as of Mar. 2026. GuruFocus rates XKLS:0243 with a GF Score™ of 61/100 and a GF Value™ of RM0.29 (Significantly Undervalued). The stock has 5 warning signs investors should review.

Cengild Medical Bhd's Ending Cash Position for the quarter that ended in Mar. 2026 was RM36.36 Mil.

Cengild Medical Bhd's quarterly Ending Cash Position increased from Sep. 2025 (RM23.91 Mil) to Dec. 2025 (RM46.60 Mil) but then declined from Dec. 2025 (RM46.60 Mil) to Mar. 2026 (RM36.36 Mil).

Cengild Medical Bhd's annual Ending Cash Position declined from Jun. 2023 (RM98.31 Mil) to Jun. 2024 (RM23.36 Mil) but then increased from Jun. 2024 (RM23.36 Mil) to Jun. 2025 (RM33.68 Mil).

Cengild Medical Bhd Ending Cash Position Related Terms

Cengild Medical Bhd Ending Cash Position Historical Data

* Premium members only.

The historical data trend for Cengild Medical Bhd's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cengild Medical Bhd Ending Cash Position Chart

Cengild Medical Bhd Annual Data
Trend Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Ending Cash Position
Get a 7-Day Free Trial 4.23 36.39 98.31 23.36 33.68

Cengild Medical Bhd Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 24.36 33.68 23.91 46.60 36.36
XKLS:0243
61GF Score
Cengild Medical Bhd XKLS:0243
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cengild Medical Bhd Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Cengild Medical Bhd's Ending Cash Position for the fiscal year that ended in Jun. 2025 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=23.363+10.318
=33.68

Cengild Medical Bhd's Ending Cash Position for the quarter that ended in Mar. 2026 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=46.594+-10.231
=36.36

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of RM36.36 Mil mean?
Cengild Medical Bhd (XKLS:0243) has a Ending Cash Position of RM36.36 Mil as of Mar. 2026. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Cengild Medical Bhd and its competitors.
Is Cengild Medical Bhd's Ending Cash Position too high?
Cengild Medical Bhd's current Ending Cash Position is RM36.36 Mil. Overall, Cengild Medical Bhd has a GF Score™ of 61/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Cengild Medical Bhd's Ending Cash Position compare to HCA and THC?
Cengild Medical Bhd's Ending Cash Position of RM36.36 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Healthcare Providers & Services company?
A good Ending Cash Position depends on the Healthcare Providers & Services industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Cengild Medical Bhd and its competitors. Cengild Medical Bhd's current Ending Cash Position is RM36.36 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cengild Medical Bhd stock overvalued right now?
Based on GuruFocus' analysis, Cengild Medical Bhd (XKLS:0243) is currently considered Significantly Undervalued. The stock's GF Value™ is RM0.29, compared to a current price of RM0.19 — trading 34.5% below its estimated fair value. The current Ending Cash Position is RM36.36 Mil. Cengild Medical Bhd's overall GF Score™ is 61/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For Cengild Medical Bhd (XKLS:0243), the current Ending Cash Position is RM36.36 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cengild Medical Bhd (XKLS:0243) Overvalued in 2026?

Based on GuruFocus' analysis, Cengild Medical Bhd stock appears to be undervalued. The current stock price of RM0.19 is trading 34.5% below its estimated GF Value™ of RM0.29. GuruFocus considers Cengild Medical Bhd to be Significantly Undervalued.

Key valuation signals for XKLS:0243:

  • Ending Cash Position: RM36.36 Mil
  • GF Value™: RM0.29 vs. price of RM0.19 (34.5% below fair value)
  • GF Score™: 61/100 with 5 warning signs

No single metric tells the full story. See the XKLS:0243 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cengild Medical Bhd Business Description

Address No.7, Jalan Kerinchi, Unit 2-3 & 2-4, Level 2, Nexus, Bangsar South, Kuala Lumpur, MYS, 59200
Cengild Medical Bhd is a healthcare service provider operating a medical centre specializing in the diagnosis and treatment of gastrointestinal-related diseases, oncology, gynecology services., liver diseases, and obesity. The company operates in Malaysia and has two reportable segments, Consultant Services and Medical Management Services. A substantial portion of the overall revenue is generated from its Medical Management Services segment.
61GF Score

Get the complete analysis for XKLS:0243

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

RM0.19
Price
RM0.29
GF Value